The United States Embassy said Tuesday that Zimbabwe has been selected as one of 10 countries worldwide to roll out lenacapavir, a twice-yearly HIV prevention drug described as a breakthrough in the fight against the epidemic.
“Yes Zimbabwe, it’s happening! We are excited to announce that Zimbabwe was selected as one of the ten countries globally to roll out lenacapavir, a breakthrough development in the fight against HIV,” the embassy said in a statement.
The rollout is being delivered through a partnership with U.S.-based Gilead Sciences and the Global Fund.
“In a large-scale clinical trial more than 99% of people on lenacapavir remained HIV negative. While this has the potential to save millions of lives, here in Zimbabwe it represents a major step toward ending new infections,” the statement said.
The embassy added that the initiative is about more than medicine.
“By focusing on pregnant and breastfeeding women, we’re protecting the next generation. By strengthening healthcare systems, we’re empowering Zimbabwe to lead its own fight against HIV. And by making lenacapavir more affordable and accessible, no one is left behind,” it said.
“This is American leadership at its best: driving innovation, and building a world where children, mothers, and communities can thrive,” the embassy said. “Together, we’re not just fighting HIV—we’re winning.”
Kukurigo Updates©️